Arcinova Info Sheet: Drug Substance Synthesis & Manufacturing

Bespoke drug substance synthesis and drug substance manufacturing, helping to accelerate molecules from candidate selection onwards. 

Arcinova, A Quotient Sciences Company, offers phase-appropriate drug substance manufacturing that accelerates the journey from candidate selection to clinical proof-of-concept. With a focus on flexibility and customization, Arcinova integrates advanced technologies and deep scientific expertise to streamline early development, reduce risk, and minimize time to IND/IMPD submission.

Leveraging decades of combined experience in synthetic organic chemistry, flow chemistry, synthetic biology, and biocatalysis, our team of PhD-level scientists deliver robust, scalable, and regulatory-compliant synthesis solutions. From route scouting and process R&D to GMP and non-GMP drug substance manufacturing, Arcinova provides end-to-end services including salt and polymorph screening, analytical method development, impurity profiling, and ICH stability studies. We use an agile model for efficient API development, ensuring that drug substance supply remains off the critical path. 

Download our info sheet to learn more about our services for drug substance development.